Peter Anevski has bought PGNY on 2 days since Dec 2024
CEO at Progyny, Inc.
SEC CIK 0001576147 · Filings on SEC.gov ↗
Peter Anevski's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Every filing
69 filings since Oct 2019, newest first
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
CEO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
Progyny, Inc.
President and COO
About Peter Anevski
Peter Anevski is the Chief Executive Officer and a director of Progyny, Inc. (PGNY) since January 2022, having previously served as the company's Chief Operating Officer (2017–2021), President (2019–2021), and Chief Financial Officer (2017–2020).( Prior to joining Progyny, he held the role of Executive Vice President and CFO at WebMD from 2013 to 2016, following 14 years in senior finance and operations positions at WebMD and its predecessors.( He holds a B.A. in Accounting from Montclair State University and is a member of the New Jersey State Society of Certified Public Accountants and the American Institute of Certified Public Accountants.(
Under Anevski's leadership, Progyny achieved record revenue of $1.167 billion in 2024 (+7.2% YoY) and expanded services into pregnancy, postpartum, and menopause care, serving over 1.5 million lives with high Net Promoter Scores (+79 fertility, +84 Rx).( He brings over two decades of experience scaling operations in healthcare, is a recipient of Ernst & Young's Entrepreneur of the Year 2024 New York Award, and Progyny was named to TIME 100's Most Influential Companies list for 2024.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.